Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $2.30 billion. The enterprise value is $1.87 billion.
| Market Cap | 2.30B |
| Enterprise Value | 1.87B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 112.35 million shares outstanding. The number of shares has increased by 8.42% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 112.35M |
| Shares Change (YoY) | +8.42% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 55.75% |
| Float | 91.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.08 |
| Forward PS | 4.94 |
| PB Ratio | 3.44 |
| P/TBV Ratio | 3.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.40 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.85 |
Financial Efficiency
Return on equity (ROE) is -24.19% and return on invested capital (ROIC) is -15.98%.
| Return on Equity (ROE) | -24.19% |
| Return on Assets (ROA) | -13.36% |
| Return on Invested Capital (ROIC) | -15.98% |
| Return on Capital Employed (ROCE) | -34.51% |
| Weighted Average Cost of Capital (WACC) | 7.85% |
| Revenue Per Employee | $254,081 |
| Profits Per Employee | -$99,840 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.99 |
Taxes
| Income Tax | -1.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.54% in the last 52 weeks. The beta is 0.76, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -42.54% |
| 50-Day Moving Average | 18.83 |
| 200-Day Moving Average | 20.93 |
| Relative Strength Index (RSI) | 69.51 |
| Average Volume (20 Days) | 948,291 |
Short Selling Information
The latest short interest is 7.25 million, so 6.57% of the outstanding shares have been sold short.
| Short Interest | 7.25M |
| Short Previous Month | 6.53M |
| Short % of Shares Out | 6.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.54 |
Income Statement
In the last 12 months, Zai Lab had revenue of $453.28 million and -$178.12 million in losses. Loss per share was -$1.62.
| Revenue | 453.28M |
| Gross Profit | 36.75M |
| Operating Income | -242.51M |
| Pretax Income | -179.60M |
| Net Income | -178.12M |
| EBITDA | -227.01M |
| EBIT | -242.51M |
| Loss Per Share | -$1.62 |
Balance Sheet
The company has $661.32 million in cash and $231.91 million in debt, with a net cash position of $429.41 million or $3.82 per share.
| Cash & Cash Equivalents | 661.32M |
| Total Debt | 231.91M |
| Net Cash | 429.41M |
| Net Cash Per Share | $3.82 |
| Equity (Book Value) | 661.98M |
| Book Value Per Share | 5.96 |
| Working Capital | 551.75M |
Cash Flow
In the last 12 months, operating cash flow was -$101.00 million and capital expenditures -$7.76 million, giving a free cash flow of -$108.76 million.
| Operating Cash Flow | -101.00M |
| Capital Expenditures | -7.76M |
| Depreciation & Amortization | 15.50M |
| Net Borrowing | 33.97M |
| Free Cash Flow | -108.76M |
| FCF Per Share | -$0.97 |
Margins
Gross margin is 8.11%, with operating and profit margins of -53.50% and -39.29%.
| Gross Margin | 8.11% |
| Operating Margin | -53.50% |
| Pretax Margin | -39.62% |
| Profit Margin | -39.29% |
| EBITDA Margin | -50.08% |
| EBIT Margin | -53.50% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.74% |
| FCF Yield | -4.72% |
Analyst Forecast
The average price target for Zai Lab is $33.30, which is 62.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.30 |
| Price Target Difference | 62.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 17.99% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of 1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 3 |